DiscoverMarkets & Money Today | 2 Min News | The Daily News Now!Wegovy vs. Medicaid: States Rethink Obesity Drug Coverage
Wegovy vs. Medicaid: States Rethink Obesity Drug Coverage

Wegovy vs. Medicaid: States Rethink Obesity Drug Coverage

Update: 2025-10-21
Share

Description

Wegovy vs. Medicaid: States are rethinking coverage for Novo Nordisk’s blockbuster obesity drug as costs skyrocket, leaving millions of low-income Americans at risk of losing access to this potentially life-changing treatment. Will states prioritize immediate budget concerns or long-term health benefits? The battle is on.

The Daily News Now! — Every city. Every story. AI-powered.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Wegovy vs. Medicaid: States Rethink Obesity Drug Coverage

Wegovy vs. Medicaid: States Rethink Obesity Drug Coverage